Literature DB >> 21680531

Assessment of the genetic susceptibility of sheep to scrapie by protein misfolding cyclic amplification and comparison with experimental scrapie transmission studies.

Cecilia Bucalossi1, Gianmario Cosseddu, Claudia D'Agostino, Michele Angelo Di Bari, Barbara Chiappini, Michela Conte, Francesca Rosone, Luigi De Grossi, Gaia Scavia, Umberto Agrimi, Romolo Nonno, Gabriele Vaccari.   

Abstract

The susceptibility of sheep to scrapie is influenced mainly by the prion protein polymorphisms A136V, R154H, and Q171R/H. Here we analyzed the ability of protein misfolding cyclic amplification (PMCA) to model the genetic susceptibility of sheep to scrapie. For this purpose, we studied the efficiency of brain homogenates from sheep with different PrP genotypes to support PrP(Sc) amplification by PMCA using an ARQ/ARQ scrapie inoculum. The results were then compared with those obtained in vivo using the same sheep breed, genotypes, and scrapie inoculum. Genotypes associated with susceptibility (ARQ/ARQ, ARQ/AHQ, and AHQ/ARH) were able to sustain PrP(Sc) amplification in PMCA reactions, while genotypes associated with resistance to scrapie (ARQ/ARR and ARR/ARR) were unable to support the in vitro conversion. The incubation times of the experimental infection were then compared with the in vitro amplification factors. Linear regression analysis showed that the efficiency of in vitro PrP(Sc) amplification of the different genotypes was indeed inversely proportional to their incubation times. Finally, the rare ARQK₁₇₆/ARQK₁₇₆ genotype, for which no in vivo data are available, was studied by PMCA. No amplification was obtained, suggesting ARQK₁₇₆/ARQK₁₇₆ as an additional genotype associated with resistance, at least to the isolate tested. Our results indicate a direct correlation between the ability of different PrP genotypes to undergo PrP(C)-to-PrP(Sc) conversion by PMCA and their in vivo susceptibility and point to PMCA as an alternative to transmission studies and a potential tool to test the susceptibility of numerous sheep PrP genotypes to a variety of prion sources.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680531      PMCID: PMC3147950          DOI: 10.1128/JVI.00241-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  PrP genotype in Sarda breed sheep and its relevance to scrapie. Brief report.

Authors:  G Vaccari; R Petraroli; U Agrimi; C Eleni; M G Perfetti; M A Di Bari; L Morelli; C Ligios; L Busani; R Nonno; G Di Guardo
Journal:  Arch Virol       Date:  2001-10       Impact factor: 2.574

2.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.

Authors:  G P Saborio; B Permanne; C Soto
Journal:  Nature       Date:  2001-06-14       Impact factor: 49.962

3.  PrPSc accumulation in myocytes from sheep incubating natural scrapie.

Authors:  O Andréoletti; S Simon; C Lacroux; N Morel; G Tabouret; A Chabert; S Lugan; F Corbière; P Ferré; G Foucras; H Laude; F Eychenne; J Grassi; F Schelcher
Journal:  Nat Med       Date:  2004-05-23       Impact factor: 53.440

4.  Low frequency of the scrapie resistance-associated allele and presence of lysine-171 allele of the prion protein gene in Italian Biellese ovine breed.

Authors:  P L Acutis; L Sbaiz; F Verburg; M V Riina; G Ru; G Moda; M Caramelli; A Bossers
Journal:  J Gen Virol       Date:  2004-10       Impact factor: 3.891

5.  Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP.

Authors:  A Bossers; R de Vries; M A Smits
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  A cellular gene encodes scrapie PrP 27-30 protein.

Authors:  B Oesch; D Westaway; M Wälchli; M P McKinley; S B Kent; R Aebersold; R A Barry; P Tempst; D B Teplow; L E Hood
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

Review 7.  The genetics of scrapie in sheep and goats.

Authors:  M Baylis; W Goldmann
Journal:  Curr Mol Med       Date:  2004-06       Impact factor: 2.222

8.  Dominant-negative inhibition of prion replication in transgenic mice.

Authors:  Véronique Perrier; Kiyotoshi Kaneko; Jiri Safar; Julie Vergara; Patrick Tremblay; Stephen J DeArmond; Fred E Cohen; Stanley B Prusiner; Andrew C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

9.  Two alleles of a neural protein gene linked to scrapie in sheep.

Authors:  W Goldmann; N Hunter; J D Foster; J M Salbaum; K Beyreuther; J Hope
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

10.  Risk of scrapie in British sheep of different prion protein genotype.

Authors:  M Baylis; C Chihota; E Stevenson; W Goldmann; A Smith; K Sivam; S Tongue; M B Gravenor
Journal:  J Gen Virol       Date:  2004-09       Impact factor: 3.891

View more
  11 in total

1.  Sensitivity of protein misfolding cyclic amplification versus immunohistochemistry in ante-mortem detection of chronic wasting disease.

Authors:  Nicholas J Haley; Candace K Mathiason; Scott Carver; Glenn C Telling; Mark D Zabel; Edward A Hoover
Journal:  J Gen Virol       Date:  2012-01-25       Impact factor: 3.891

2.  Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains.

Authors:  Nicolas Privat; Etienne Levavasseur; Serfildan Yildirim; Samia Hannaoui; Jean-Philippe Brandel; Jean-Louis Laplanche; Vincent Béringue; Danielle Seilhean; Stéphane Haïk
Journal:  J Biol Chem       Date:  2017-08-15       Impact factor: 5.157

3.  Design, implementation, and interpretation of amplification studies for prion detection.

Authors:  Nicholas J Haley; Jürgen A Richt; Kristen A Davenport; Davin M Henderson; Edward A Hoover; Matteo Manca; Byron Caughey; Douglas Marthaler; Jason Bartz; Sabine Gilch
Journal:  Prion       Date:  2018-03-09       Impact factor: 3.931

4.  Estimating chronic wasting disease susceptibility in cervids using real-time quaking-induced conversion.

Authors:  Nicholas J Haley; Rachel Rielinger; Kristen A Davenport; Katherine O'Rourke; Gordon Mitchell; Jürgen A Richt
Journal:  J Gen Virol       Date:  2017-10-23       Impact factor: 3.891

5.  Biodiversity and selection for scrapie resistance in sheep: genetic polymorphism in eight breeds of Algeria.

Authors:  Amal Djaout; Barbara Chiappini; S Bechir Suheil Gaouar; Farida Afri-Bouzebda; Michela Conte; Fakhreddine Chekkal; Rachid El-Bouyahiaoui; Rachid Boukhari; Umberto Agrimi; Gabriele Vaccari
Journal:  J Genet       Date:  2018-06       Impact factor: 1.166

6.  Naturally prion resistant mammals: a utopia?

Authors:  Natalia Fernández-Borges; Francesca Chianini; Hasier Eraña; Enric Vidal; Samantha L Eaton; Belén Pintado; Jeanie Finlayson; Mark P Dagleish; Joaquín Castilla
Journal:  Prion       Date:  2012-09-06       Impact factor: 3.931

7.  Enhanced virulence of sheep-passaged bovine spongiform encephalopathy agent is revealed by decreased polymorphism barriers in prion protein conversion studies.

Authors:  Jan Priem; Jan P M Langeveld; Lucien J M van Keulen; Fred G van Zijderveld; Olivier Andreoletti; Alex Bossers
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

8.  Fast and ultrasensitive method for quantitating prion infectivity titre.

Authors:  Natallia Makarava; Regina Savtchenko; Irina Alexeeva; Robert G Rohwer; Ilia V Baskakov
Journal:  Nat Commun       Date:  2012-03-13       Impact factor: 14.919

9.  In vitro amplification of ovine prions from scrapie-infected sheep from Great Britain reveals distinct patterns of propagation.

Authors:  Leigh Thorne; Thomas Holder; Andrew Ramsay; Jane Edwards; Maged Mohamed Taema; Otto Windl; Ben Charles Maddison; Kevin Christopher Gough; Linda Ann Terry
Journal:  BMC Vet Res       Date:  2012-11-15       Impact factor: 2.741

10.  In vitro prion protein conversion suggests risk of bighorn sheep (Ovis canadensis) to transmissible spongiform encephalopathies.

Authors:  Aaron R Morawski; Christina M Carlson; Haeyoon Chang; Christopher J Johnson
Journal:  BMC Vet Res       Date:  2013-08-09       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.